98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00520-024-08820-9 | DOI Listing |
Pain Rep
October 2025
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Introduction: Moderate-to-severe acute postsurgical pain (APSP) is experienced by approximately 30% of surgical patients.
Objectives: To improve early APSP management, we developed 2 pragmatic and generalizable point-of-care risk tools to preoperatively predict moderate-to-severe and severe APSP in the postanaesthesia care unit (PACU).
Methods: This was a multicenter prospective cohort study of adult patients undergoing elective surgical procedures between May 2021 and May 2023.
BMJ Case Rep
August 2025
Department of Anesthesiology, National Hospital Organization Higashi Hiroshima Medical Center, Higashihiroshima, Hiroshima Prefecture, Japan.
Charcot-Marie-Tooth (CMT) disease is a progressive hereditary neuropathy that complicates anaesthesia because of neuromuscular-blocker sensitivity. Remimazolam, an ultra-short-acting benzodiazepine, has not yet been reported in CMT. We anaesthetised a woman in her 70s with CMT type 1A and cardiac sarcoidosis for femoral nail fixation under total intravenous anaesthesia with remimazolam and remifentanil.
View Article and Find Full Text PDFHealth Justice
August 2025
Schar School of Public Policy, George Mason University, Fairfax, USA.
Background: Criminal legal involved (CLI) individuals face a heightened risk of opioid misuse and overdose, yet access to medications for opioid use disorder (MOUD) is limited, particularly in criminal legal settings. Negative attitudes and misinformation about MOUD are prevalent among legal system actors, creating a barrier to MOUD access. This study examines the effectiveness of informational and narrative messages in correcting misinformation and promoting positive attitudes toward MOUD among criminal legal system (CLS) professionals.
View Article and Find Full Text PDFFront Pediatr
August 2025
Tufts Clinical and Translational Science Institute, Boston, MA, United States.
Objective: Development and validation of a clinical prediction model for receipt of pharmacotherapy for Neonatal Abstinence Syndrome (NAS).
Study Design: Data from three cohorts included opioid exposed neonates ≥37 weeks gestation. Primary outcome was the receipt of pharmacotherapy utilizing a modified Finnegan Neonatal Abstinence Scoring System (FNASS).
J Integr Complement Med
August 2025
Research Institute, BC Children's Hospital, Vancouver, Canada.
The minimally invasive repair of pectus excavatum (MIRPE), a surgical procedure done primarily in adolescence to correct pectus excavatum (PE), a congenital chest wall deformity, is associated with significant postoperative pain and opioid consumption. The use of an integrative medicine (IM) approach-combining complementary therapies with conventional treatments-can support postoperative pain management and potentially reduce opioid consumption in adolescent patients undergoing this procedure. This scoping review examines the published literature addressing the use of IM modalities in adolescent patients undergoing MIRPE.
View Article and Find Full Text PDF